Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Expensify Inc (EXFY) vs InMode Ltd (INMD) Price & Performance

Expensify IncTrade
InMode LtdTrade

Price performance (Past 24H)

Key statistics

Expensify Inc vs InMode Ltd — how do they compare? Expensify Inc trades at $2.27 (market cap $209.73M), while InMode Ltd trades at $15.25 (market cap $872.08M). The key difference: InMode Ltd is far larger — about 4.2× Expensify Inc's market cap, and Expensify Inc is trading nearer its 52-week high, InMode Ltd nearer its low. Which is the better fit depends on your goals.

EXFYINMD
Market Cap
$209.73M$872.08M
Sector
TechnologyTechnology
52-Week High
$2.69$16.62
52-Week Low
$0.75$12.76
Enterprise Value
$149.35M$375.42M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Expensify Inc

Expensify (EXFY) trades at $2.22, down 10.12% in the past 24 hours, with a bullish technical signal from moving averages and a neutral RSI. Recent Q2 2026 earnings showed a beat on EPS and a return to non-GAAP profitability, with revenue of $33.9 million. The company is expanding its AI-native solutions and European card offerings, supported by positive cash flow trends.

Outlook is cautiously optimistic due to earnings improvements and strategic expansions, but risks include persistent net losses, high P/E ratio of 258.82, and competitive pressures in expense management software. Analyst consensus is mixed with 44% buy ratings.

InMode Ltd

INMD trades at $15.23, up 0.26% today, with a neutral technical outlook and mixed earnings history including a Q1 2026 miss. The company reported Q2 2026 revenue of $95.6 million, consistent year-over-year, and maintains a strong gross profit margin of 76.52%. Recent news highlights an unsolicited acquisition offer from Steel Partners at $16.75 per share and shareholder activism urging rejection, creating uncertainty around corporate governance.

The stock presents a value opportunity with low P/E and EV/EBITDA ratios, but risks include earnings volatility, potential acquisition fallout, and ongoing securities fraud investigations. Analyst consensus is divided between Buy and Hold ratings, reflecting cautious optimism amid near-term headwinds. Long-term growth depends on execution of international expansion and innovation in medical technologies.

Returns comparison

Trailing returns across standard periods

About Expensify Inc

Expensify Inc is a cloud-based expense management software platform that helps the smallest to the largest businesses simplify the way they manage money. More than 10 million people use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay, and travel booking in one app.

Read more on EXFY

About InMode Ltd

InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.

Read more on INMD